MIND studies neurodegenerative disorders, most importantly Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease, Huntington's disease, and Parkinson's disease.

Amyotrophic Lateral Sclerosis

ALS, or Lou Gehrig’s disease, is a life-threatening neurodegenerative disease with an estimated prevalence in the United States of 30,000 and an average life expectancy from diagnosis of only two to five years.

Introduction to ALS Research   Healey Center for ALS

Alzheimer’s Disease

Alzheimer’s disease (AD) is a neurodegenerative disease affecting approximately 10% of individuals over the age of 65 and nearly one-third of those over 85, making it the most common cause of dementia. Over 300 billion dollars are spent on Alzheimer's care each year.

Introduction to Alzheimer's Research   Memory Disorders Division

Huntington’s Disease

Huntington’s disease (HD) is one of the more common neurodegenerative diseases with an estimated 250,000 people in the United States either diagnosed with, or at risk for, the disease. The typical age of HD onset is between the ages of 30 and 50, with very rare juvenile onset as young as two years old and the average lifespan once diagnosed with HD is 10-20 years.

Introduction to HD Research   Huntington's Center of Excellence

Parkinson’s Disease

The second most frequently diagnosed neurodegenerative disease after Alzheimer’s disease is Parkinson’s disease (PD). PD onset is usually after the age of 60 and affects about five million people globally. This number is expected to keep rising as the population ages.

Introduction to Parkinson's Research   Parkinson's & Movement Disorders Clinic